SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001520138-23-000131
Filing Date
2023-03-13
Accepted
2023-03-13 17:19:05
Documents
13
Period of Report
2023-03-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20230313_8k.htm   iXBRL 8-K 37228
2 EXHIBIT 3.1 bivi-20230313_8kex3z1.htm EX-3.1 8666
  Complete submission text file 0001520138-23-000131.txt   224262

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bivi-20230312.xsd EX-101.SCH 3239
4 XBRL LABEL FILE bivi-20230312_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bivi-20230312_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20230313_8k_htm.xml XML 3718
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 23728236
SIC: 2834 Pharmaceutical Preparations